Skip to main content

Table 2 Abdominal CT-Based body fat-muscle composition measures and BMI in SLE patients with hypertension and SLE patients without hypertension

From: Association between myosteatosis or sarcopenia based on abdominal CT and hypertension in systemic lupus erythematosus patients

Parameter

Overall

(n = 279)

Absence of hypertension

(n = 200)

Presence of hypertension

(n = 79)

Statistic

P Value

Myosteatosis

   

χ²=9.86

0.002

No, n (%)

76 (27.2)

65 (32.5)

11(13.9)

  

Yes, n (%)#

203 (72.8)

135 (67.5)

68 (86.1)

  

SMD, HU

33.64 ± 8.11

34.69 ± 8.12

30.98 ± 7.50

t = 3.52

< 0.001

Sarcopenia

   

χ²=3.02

0.082

No, n (%)

115 (41.2)

76 (38.0)

39 (49.4)

  

Yes, n (%)§

164 (58.8)

124 (62.0)

40 (50.6)

  

SMI, cm2/m2

38.13 (33.12, 43.22)

37.92 (32.97, 43.84)

39.13 (33.37, 43.14)

Z=-0.31

0.759

IMAT, cm2

7.95 (4.96, 12.81)

7.59 (4.71, 11.96)

10.87 (6.07, 14.72)

Z=-2.61

0.009

VAT, cm2

73.25 (44.78, 125.5)

65.28 (43.39, 106.00)

114.20 (64.12, 150.60)

Z=-4.19

< 0.001

SAT, cm2

122.00 (85.65, 178.90)

115.35 (81.23, 166.18)

147.50 (99.62, 198.50)

Z=-2.78

0.005

VAT/SAT

0.61 (0.42, 0.88)

0.57 (0.40, 0.81)

0.68 (0.47, 1.09)

Z=-2.85

0.004

  1. §Sarcopenia was considered as a binary variable
  2. #Myosteatosis was considered as a binary variable
  3. Abbreviation: SLE, systemic lupus erythematosus; BMI, body mass index; SMD, skeletal muscle radiodensity; SMI, skeletal muscle index; IMAT, intramuscular adipose tissue; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue